Government’s health committee calls for publication of all pharmaceutical trial data.
Latest Stories
Male health initiatives get less money than those aimed at women
London’s PCTs spend less on outreach, preventative health services aimed at men.
In poor health: London’s shocking disparity in men’s life expectancy
Men in some parts of London live 17 years less than those in wealthier areas.
Why is men’s health suffering in London?
Initiatives by football clubs aim to increase life expectancy among men, but it’s still too low.
Get the data: Spending on male health and wellbeing services
London boroughs spend significantly less on male health and well-being services.
Men’s health: A correlation between the gender gap and deprivation?
Areas in the more deprived parts of London have big gaps between female and male life expectancy.
Circle Holdings eyes hospital bid as share price plummets
Circle Health’s share price looks less then healthy as it seeks to expand
UN criticised in Sudan after children left unimmunised
Nuba mountains children left without immunological protection after UN pull out.
Saudi ban on women’s sports blamed for rising obesity
Saudi women are often banned from playing sports… with health consequences.
GMC moves to stop gagging clauses in NHS
Doctors must be able to report malpractice, GMC rules, following Bureau investigation.
Pharma company hid vital data on Tamiflu, scientists claim
Roche is accused of hindering investigation into billion-dollar swine flu drug.
DoH lack of transparency hides £470m spent on management consultants
Over twice spent on management consultants than centrally recorded.
Analysis: Unhealthy friendships with Department of Health
Andrew Lansley’s special adviser worked for PR firm with food and health interests.
Struck-off chiropractor still working as ‘spine specialist’
Case illustrates regulatory loophole that allows those struck-off to keep practising.
Was trial of blockbuster anti-depressant truly independent?
Questions raised over independence of evidence in trials of a major NHS anti-depressant drug.
Analysis: NHS should take note of OFT investigation
Is regulator’s investigation into private healthcare market a warning of things to come in NHS?
Analysis: Legal case in India threatens HIV drug access for poorest
Court case in India could have devastating impact on supply of cheap drugs to developing world.
Inequity in international public health spending
Why do headline-grabbing tropical diseases receive substantially more funding than others?
Virgin Health Bank promises fail to live up to expectations
The charitable element of the stem cell storage service has not been taken up by the NHS.
Analysis: Will the NHS ever be truly transparent?
The ‘duty of candour’ policy will make transparency a contractual obligation.
